Canadian Imperial Bank of Commerce
CM
Bank of Nova Scotia
BNS
Royal Bank of Canada
RY
4
Bank of Montreal
BMO
5
The Toronto-Dominion Bank
TD
Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.